Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line

Cancer Science

Volumn 101, Issue 12, 2010, Pages 2546-2553

  Li, Guo Cai ^a   Ye, Qing Hai ^a   Xue, Yu Hua ^a   Sun, Hai Jing ^a   Zhou, Hai Jun ^a   Ren, Ning ^a   Jia, Hu Liang ^a   Shi, Jiong ^a   Wu, Jin Cai ^a   Dai, Chun ^a   Dong, Qiong Zhu ^a   Qin, Lun Xiu ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; MESSENGER RNA; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER MODEL; CELL COUNT; CELL FUNCTION; CELL INVASION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; LUNG METASTASIS; MESENCHYME CELL; METASTASIS INHIBITION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; TUMOR VOLUME;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; COCULTURE TECHNIQUES; HUMANS; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 2; MESENCHYMAL STEM CELLS; MICE; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFORMING GROWTH FACTOR BETA1; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 78449302417     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01738.x     Document Type: Article

References (42)

1. Parkin D, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. He J, Gu D, Wu X et al. Major causes of death among men and women in China. N Engl J Med 2005; 353: 1124-34.
3. Portolani N, Coniglio A, Ghidoni S et al. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 2006; 243: 229-35.
4. Ye Q, Qin L, Forgues M et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 2003; 9: 416-23.
5. Qin L, Tang Z. Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature. J Cancer Res Clin Oncol 2004; 130: 497-513.
6. Coussens L, Tinkle C, Hanahan D, Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000; 103: 481-90.
7. Lyden D, Hattori K, Dias S et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001; 7: 1194-201.
8. Chanda D, Isayeva T, Kumar S et al. Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in prostate cancer bone metastasis. Clin Cancer Res 2009; 15: 7175-85.
9. Sasportas L, Kasmieh R, Wakimoto H et al. Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy. Proc Natl Acad Sci U S A 2009; 106: 4822-7.
10. Fritz V, Jorgensen C. Mesenchymal stem cells: an emerging tool for cancer targeting and therapy. Curr Stem Cell Res Ther 2008; 3: 32-42.
11. Karnoub A, Dash A, Vo A et al. Mesenchymal stem cells within tumor stroma promote breast cancer metastasis. Nature 2007; 449: 557-63.
12. Alison M, Lovell M. Liver cancer: the role of stem cells. Cell Prolif 2005; 38: 407-21.
13. Pittenger M, Mackay A, Beck S et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-7.
14. Minguell J, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med (Maywood) 2001; 226: 507-20.
15. Jiang Y, Jahagirdar B, Reinhardt R et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-9.
16. Liechty K, MacKenzie T, Shaaban A et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2000; 6: 1282-6.
17. Studeny M, Marini F, Dembinski J et al. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 2004; 96: 1593-603.
18. Fierro F, Sierralta W, Epuñan M, Minguell J. Marrow-derived mesenchymal stem cells: role in epithelial tumor cell determination. Clin Exp Metastasis 2004; 21: 313-9.
19. Ohlsson L, Varas L, Kjellman C, Edvardsen K, Lindvall M. Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix. Exp Mol Pathol 2003; 75: 248-55.
20. Zhu Y, Sun Z, Han Q et al. Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1. Leukemia 2009; 23: 925-33.
21. Li Y, Tang Y, Ye L et al. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J Cancer Res Clin Oncol 2003; 129: 43-51.
22. Giannelli G, Fransvea E, Marinosci F et al. Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin. Am J Pathol 2002; 161: 183-93.
23. Prockop D. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71-4.
24. Dvorak H. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315: 1650-9.
25. Littlepage L, Egeblad M, Werb Z. Coevolution of cancer and stromal cellular responses. Cancer Cell 2005; 7: 499-500.
26. Son B, Marquez-Curtis L, Kucia M et al. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 2006; 24: 1254-64.
27. Scadden D. The stem-cell niche as an entity of action. Nature 2006; 441: 1075-9.
28. Kulterer B, Friedl G, Jandrositz A et al. Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics 2007; 8: 70.
29. Woodward J, Rennie I, Burn J, Sisley K. A potential role for TGFbeta in the regulation of uveal melanoma adhesive interactions with the hepatic endothelium. Invest Ophthalmol Vis Sci 2005; 46: 3473-7.
30. Katabami K, Mizuno H, Sano R et al. Transforming growth factor-beta1 upregulates transcription of alpha3 integrin gene in hepatocellular carcinoma cells via Ets-transcription factor-binding motif in the promoter region. Clin Exp Metastasis 2005; 22: 539-48.
31. Blobe G, Schiemann W, Lodish H. Role of transforming growth factor beta in human disease. N Engl J Med 2000; 342: 1350-8.
32. Seoane J. The TGFBeta pathway as a therapeutic target in cancer. Clin Transl Oncol 2008; 10: 14-9.
33. Padua D, Massagué J. Roles of TGFbeta in metastasis. Cell Res 2009; 19: 89-102.
34. Welm AL. TGFbeta primes breast tumor cells for metastasis. Cell 2008; 133: 27-8.
35. Chow JY, Cabral JA, Chang J, Carethers JM. TGFbeta modulates PTEN expression independently of SMAD signaling for growth proliferation in colon cancer cells. Cancer Biol Ther 2008; 7: 1694-9.
36. Gaspar NJ, Li L, Kapoun AM et al. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness. Mol Pharmacol 2007; 72: 152-61.
37. Matsuzaki K, Date M, Furukawa F et al. Autocrine stimulatory mechanism by transforming growth factor beta in human hepatocellular carcinoma. Cancer Res 2000; 60: 1394-402.
38. Tan AR, Alexe G, Reiss M. Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer? Breast Cancer Res Treat 2009; 115: 453-95.
39. Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 2000; 14: 163-76.
40. Kwak H, Park M, Cho H et al. Transforming growth factor-beta1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells. Mol Cancer Res 2006; 4: 209-20.
41. Zavadil J, Bitzer M, Liang D et al. Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc Natl Acad Sci U S A 2001; 98: 6686-91.
42. Cox G, O'Byrne KJ. Matrix metalloproteinase and cancer. Anticancer Res 2001; 21: 4207-20.